Titi-Lartey Owuraku, Mohammed Imran, Amoaku Winfried M
Academic Ophthalmology, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Front Ophthalmol (Lausanne). 2022 Mar 31;2:850394. doi: 10.3389/fopht.2022.850394. eCollection 2022.
There is growing evidence that the pathogenesis of retinal diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD) have a significant chronic inflammatory component. A vital part of the inflammatory cascade is through the activation of pattern recognition receptors (PRR) such as toll-like receptors (TLR). Here, we reviewed the past and current literature to ascertain the cumulative knowledge regarding the effect of TLRs on the development and progression of retinal diseases. There is burgeoning research demonstrating the relationship between TLRs and risk of developing retinal diseases, utilising a range of relevant disease models and a few large clinical investigations. The literature confirms that TLRs are involved in the development and progression of retinal diseases such as DR, AMD, and ischaemic retinopathy. Genetic polymorphisms in TLRs appear to contribute to the risk of developing AMD and DR. However, there are some inconsistencies in the published reports which require further elucidation. The evidence regarding TLR associations in retinal dystrophies including retinitis pigmentosa is limited. Based on the current evidence relating to the role of TLRs, combining anti-VEGF therapies with TLR inhibition may provide a longer-lasting treatment in some retinal vascular diseases.
越来越多的证据表明,糖尿病性视网膜病变(DR)和年龄相关性黄斑变性(AMD)等视网膜疾病的发病机制具有显著的慢性炎症成分。炎症级联反应的一个重要部分是通过激活模式识别受体(PRR),如Toll样受体(TLR)。在此,我们回顾了过去和当前的文献,以确定关于TLR对视网膜疾病发展和进展影响的累积知识。利用一系列相关疾病模型和一些大型临床研究,有大量研究表明TLR与发生视网膜疾病的风险之间存在关联。文献证实,TLR参与了DR、AMD和缺血性视网膜病变等视网膜疾病的发展和进展。TLR的基因多态性似乎增加了发生AMD和DR的风险。然而,已发表的报告中存在一些不一致之处,需要进一步阐明。关于TLR与包括视网膜色素变性在内的视网膜营养不良关联的证据有限。基于目前有关TLR作用的证据,在一些视网膜血管疾病中,将抗VEGF治疗与TLR抑制相结合可能会提供更持久的治疗效果。